請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/94834完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 施金元 | zh_TW |
| dc.contributor.advisor | Jin-Yuan Shih | en |
| dc.contributor.author | 陳怡伶 | zh_TW |
| dc.contributor.author | Yi-Ling Chen | en |
| dc.date.accessioned | 2024-08-19T17:17:56Z | - |
| dc.date.available | 2024-08-20 | - |
| dc.date.copyright | 2024-08-19 | - |
| dc.date.issued | 2024 | - |
| dc.date.submitted | 2024-04-25 | - |
| dc.identifier.citation | Abbaci, A., Talbot, H., Saada, S., Gachard, N., Abraham, J., Jaccard, A., et al. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis. Oncogene. 2018 Feb 8;37(6):756-767.
Adams, B. D., Parsons, C., Walker, L., Zhang, W. C., and Slack, F. J. Targeting noncoding RNAs in disease. J Clin Invest. 2017 Mar 1;127(3):761-771. Akter, H., Yoon, J. H., Yoo, Y. S., and Kang, M. J. Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer. Mol Cells. 2018 Jun;41(6):591-602. Aliahmad, P., Seksenyan, A., and Kaye, J. The many roles of TOX in the immune system. Curr Opin Immunol. 2012 Apr;24(2):173-177. Alifano, M., Souazé, F., Dupouy, S., Camilleri-Broët, S., Younes, M., Ahmed-Zaïd, S. M., et al. Neurotensin receptor 1 determines the outcome of non-small cell lung cancer. Clin Cancer Res. 2010 Sep 1;16(17):4401-4410. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000 Feb 3;403(6769):503-511. Antoniou, K. M., Tomassetti, S., Tsitoura, E., and Vancheri, C. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update. Curr Opin Pulm Med. 2015 Nov;21(6):626-633. Ayala-Sarmiento, A. E., Martinez-Fong, D., and Segovia, J. The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1. Cell Mol Neurobiol. 2015 Aug;35(6):785-795. Bade, B. C., and Dela Cruz, C. S. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1-24. Boque-Sastre, R., Soler, M., Oliveira-Mateos, C., Portela, A., Moutinho, C., Sayols, S., et al. Head-to-head antisense transcription and R-loop formation promotes transcriptional activation. Proc Natl Acad Sci U S A. 2015 May 5;112(18):5785-5790. Bounaix Morand du Puch, C., Barbier, E., Kraut, A., Couté, Y., Fuchs, J., Buhot, A., et al. TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs. Arch Biochem Biophys. 2011 Mar 15;507(2):296-303. Broderick, S. R. Adjuvant and Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer. Thorac Surg Clin. 2020 May;30(2):215-220. Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., and Rinn, J. L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011 Sep 15;25(18):1915-1927. Cai, Q., Wang, S., Jin, L., Weng, M., Zhou, D., Wang, J., et al. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol Cancer. 2019 Apr 5;18(1):82. Camidge, D. R., Pao, W., and Sequist, L. V. Acquired resistance to TKIs in solid tumours: learning from lung cancer. Nat Rev Clin Oncol. 2014 Aug;11(8):473-481. Cardarella, S., and Johnson, B. E. The impact of genomic changes on treatment of lung cancer. Am J Respir Crit Care Med. 2013 Oct 1;188(7):770-775. Carraway, R., and Leeman, S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973 Oct 10;248(19):6854-6861. Carraway, R., and Leeman, S. E. Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. J Biol Chem. 1976 Nov 25;251(22):7045-7052. Chaffer, C. L., and Weinberg, R. A. A perspective on cancer cell metastasis. Science. 2011 Mar 25;331(6024):1559-1564. Chang, T. H., Tsai, M. F., Su, K. Y., Wu, S. G., Huang, C. P., Yu, S. L., et al. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am J Respir Crit Care Med. 2011 Apr 15;183(8):1071-1079. Chang, Y. S., Choi, C. M., and Lee, J. C. Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma. Tuberc Respir Dis (Seoul). 2016 Oct;79(4):248-256. Chen, J., Chen, Y., Gu, L., Li, X., Gao, Y., Lyu, X., et al. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis. Oncotarget. 2016 Nov 8;7(45):74325-74336. Chen, J., Liu, Y., Min, J., Wang, H., Li, F., Xu, C., et al. Alternative splicing of lncRNAs in human diseases. Am J Cancer Res. 2021 11(3):624-639. Chen, L., Bao, Y., Jiang, S., and Zhong, X. B. The Roles of Long Noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in Drug Metabolism and Human Diseases. Noncoding RNA. 2020 Jun 24;6(2). Chen, S., Zhu, J., Wang, F., Guan, Z., Ge, Y., Yang, X., and Cai, J. LncRNAs and their role in cancer stem cells. Oncotarget. 2017 Dec 15;8(66):110685-110692. Chen, V. W., Ruiz, B. A., Hsieh, M. C., Wu, X. C., Ries, L. A., and Lewis, D. R. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system. Cancer. 2014 Dec 1;120 Suppl 23(0 0):3781-3792. Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-132. Chen, X., Xie, R., Gu, P., Huang, M., Han, J., Dong, W., et al. Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2. Clin Cancer Res. 2019 Feb 15;25(4):1389-1403. Chen, Y. J., Roumeliotis, T. I., Chang, Y. H., Chen, C. T., Han, C. L., Lin, M. H., et al. Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression. Cell. 2020 Jul 9;182(1):226-244.e217. Chen, Y. L., Liu, Y. N., Lin, Y. T., Tsai, M. F., Wu, S. G., Chang, T. H., et al. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis. J Biomed Sci. 2023 Sep 19;30(1):80. Chen, Z. Z., Huang, L., Wu, Y. H., Zhai, W. J., Zhu, P. P., and Gao, Y. F. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. Nat Commun. 2016 Aug 24;7:12598. Christou, N., Blondy, S., David, V., Verdier, M., Lalloué, F., Jauberteau, M. O., et al. Neurotensin pathway in digestive cancers and clinical applications: an overview. Cell Death Dis. 2020 Dec 2;11(12):1027. Clark, D. W., and Palle, K. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. Ann Transl Med. 2016 Dec;4(24):518. Clarke, M. F., and Fuller, M. Stem cells and cancer: two faces of eve. Cell. 2006 Mar 24;124(6):1111-1115. Cole, S. W., and Sood, A. K. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012 Mar 1;18(5):1201-1206. Cortazar, M. A., Sheridan, R. M., Erickson, B., Fong, N., Glover-Cutter, K., Brannan, K., and Bentley, D. L. Control of RNA Pol II Speed by PNUTS-PP1 and Spt5 Dephosphorylation Facilitates Termination by a "Sitting Duck Torpedo" Mechanism. Mol Cell. 2019 Dec 19;76(6):896-908.e894. Couraud, S., Zalcman, G., Milleron, B., Morin, F., and Souquet, P. J. Lung cancer in never smokers--a review. Eur J Cancer. 2012 Jun;48(9):1299-1311. Crick, F. Split genes and RNA splicing. Science. 1979 Apr 20;204(4390):264-271. Cui, Y., Li, G., Zhang, X., Dai, F., and Zhang, R. Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer. Oncol Lett. 2018 Oct;16(4):4821-4828. Davies, K. D., Le, A. T., Theodoro, M. F., Skokan, M. C., Aisner, D. L., Berge, E. M., et al. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. Clin Cancer Res. 2012 Sep 1;18(17):4570-4579. Deng, J., Yang, M., Jiang, R., An, N., Wang, X., and Liu, B. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells. PLoS One. 2017 12(1):e0170860. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003 4(5):P3. Devarakonda, S., Morgensztern, D., and Govindan, R. Genomic alterations in lung adenocarcinoma. Lancet Oncol. 2015 Jul;16(7):e342-351. Ding, L., Paszkowski-Rogacz, M., Winzi, M., Chakraborty, D., Theis, M., Singh, S., et al. Systems Analyses Reveal Shared and Diverse Attributes of Oct4 Regulation in Pluripotent Cells. Cell Syst. 2015 Aug 26;1(2):141-151. Dittmer, S., Kovacs, Z., Yuan, S. H., Siszler, G., Kögl, M., Summer, H., et al. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci. 2011 Jan 15;124(Pt 2):252-260. Dong, S., Qu, X., Li, W., Zhong, X., Li, P., Yang, S., et al. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. J Hematol Oncol. 2015 Apr 29;8:43. Dou, J., Ni, Y., He, X., Wu, D., Li, M., Wu, S., et al. Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells. Am J Transl Res. 2016 8(1):98-108. Duan, J. J., Cai, J., Gao, L., and Yu, S. C. ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2166035. Dupouy, S., Mourra, N., Doan, V. K., Gompel, A., Alifano, M., and Forgez, P. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers. Biochimie. 2011 Sep;93(9):1369-1378. Duruisseaux, M., and Esteller, M. Lung cancer epigenetics: From knowledge to applications. Semin Cancer Biol. 2018 Aug;51:116-128. Eberlein, C. A., Stetson, D., Markovets, A. A., Al-Kadhimi, K. J., Lai, Z., Fisher, P. R., et al. Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models. Cancer Res. 2015 Jun 15;75(12):2489-2500. Elde, R., Schalling, M., Ceccatelli, S., Nakanishi, S., and Hökfelt, T. Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors. Neurosci Lett. 1990 Nov 27;120(1):134-138. Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007 May 18;316(5827):1039-1043. Fabbri, M., Girnita, L., Varani, G., and Calin, G. A. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Res. 2019 Sep;29(9):1377-1388. Fajersztajn, L., Veras, M., Barrozo, L. V., and Saldiva, P. Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer. 2013 Sep;13(9):674-678. Fan, L., Lei, H., Lin, Y., Zhou, Z., Li, J., Wu, A., et al. Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis. Cell Mol Life Sci. 2022 Apr 22;79(5):254. Fang, Y., Sun, B., Gao, J., Huang, Y., and Wang, C. LncRNA SLCO4A1-AS1 Accelerates Growth and Metastasis of Gastric Cancer via Regulation of the miR-149/XIAP Axis. Front Oncol. 2021 11:683256. Ferris, C. F., Carraway, R. E., Hammer, R. A., and Leeman, S. E. Release and degradation of neurotensin during perfusion of rat small intestine with lipid. Regul Pept. 1985 Oct;12(2):101-111. Fu, Z., Chen, C., Zhou, Q., Wang, Y., Zhao, Y., Zhao, X., et al. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Lett. 2017 Dec 1;410:68-81. Gazdar, A. F. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene. 2009 Aug;28 Suppl 1(Suppl 1):S24-31. Gharibvand, L., Shavlik, D., Ghamsary, M., Beeson, W. L., Soret, S., Knutsen, R., and Knutsen, S. F. The Association between Ambient Fine Particulate Air Pollution and Lung Cancer Incidence: Results from the AHSMOG-2 Study. Environ Health Perspect. 2017 Mar;125(3):378-384. Grossi, E., Raimondi, I., Goñi, E., González, J., Marchese, F. P., Chapaprieta, V., et al. A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions. Nat Commun. 2020 Feb 18;11(1):936. Gu, Y., Seidl, K. J., Rathbun, G. A., Zhu, C., Manis, J. P., van der Stoep, N., et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 1997 Nov;7(5):653-665. Gudmundsdottir, E. T., Barkardottir, R. B., Arason, A., Gunnarsson, H., Amundadottir, L. T., Agnarsson, B. A., et al. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. BMC Cancer. 2012 Dec 27;12:621. Hackshaw, A. K., Law, M. R., and Wald, N. J. The accumulated evidence on lung cancer and environmental tobacco smoke. Bmj. 1997 Oct 18;315(7114):980-988. Han, B., Guan, X., Ma, M., Liang, B., Ren, L., Liu, Y., et al. Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling. Cell Oncol (Dordr). 2023 Nov 28. Hanahan, D., and Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012 Mar 20;21(3):309-322. Ho, C. C., Liao, W. Y., Lin, C. A., Shih, J. Y., Yu, C. J., and Yang, J. C. Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib. J Thorac Oncol. 2017 Mar;12(3):567-572. Houssaini, M. S., Damou, M., and Ismaili, N. Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meeting. Cancer Treat Res Commun. 2020 25:100239. Hu, G., Lou, Z., and Gupta, M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. PLoS One. 2014 9(9):e107016. Hu, H., Xu, Z., Li, C., Xu, C., Lei, Z., Zhang, H. T., and Zhao, J. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer. 2016 Jul;97:87-94. Hu, X., Ding, D., Zhang, J., and Cui, J. Knockdown of lncRNA HOTAIR sensitizes breast cancer cells to ionizing radiation through activating miR-218. Biosci Rep. 2019 Apr 30;39(4). Hu, Y. L., Lu, S., Szeto, K. W., Sun, J., Wang, Y., Lasheras, J. C., and Chien, S. FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells. Sci Rep. 2014 Aug 12;4:6024. Huang, C. P., Tsai, M. F., Chang, T. H., Tang, W. C., Chen, S. Y., Lai, H. H., et al. ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett. 2013 Jan 1;328(1):144-151. Huang, J., Lou, J., Liu, X., and Xie, Y. LncRNA PCGsEM1 Contributes to the Proliferation, Migration and Invasion of Non-small Cell Lung Cancer Cells via acting as a Sponge for miR-152-3p. Curr Pharm Des. 2021 27(46):4663-4670. Huang, L., and Fu, L. Mechanisms of resistance to EGFR tyrosine kinase inhibitors. Acta Pharm Sin B. 2015 Sep;5(5):390-401. Huang, P., Zhu, S., Liang, X., Zhang, Q., Liu, C., and Song, L. Revisiting Lung Cancer Metastasis: Insight From the Functions of Long Non-coding RNAs. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211038488. Hwang, S. J., Cheng, L. S., Lozano, G., Amos, C. I., Gu, X., and Strong, L. C. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet. 2003 Aug;113(3):238-243. Imyanitov, E. N., Iyevleva, A. G., and Levchenko, E. V. Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives. Crit Rev Oncol Hematol. 2021 Jan;157:103194. Janerich, D. T., Thompson, W. D., Varela, L. R., Greenwald, P., Chorost, S., Tucci, C., et al. Lung cancer and exposure to tobacco smoke in the household. N Engl J Med. 1990 Sep 6;323(10):632-636. Jiang, F., Qiu, Q., Khanna, A., Todd, N. W., Deepak, J., Xing, L., et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009 Mar;7(3):330-338. Jiang, J., Greulich, H., Janne, P. A., Sellers, W. R., Meyerson, M., and Griffin, J. D. Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression. Cancer Res. 2005 Oct 1;65(19):8968-8974. Jiang, J., Jing, Y., Cost, G. J., Chiang, J. C., Kolpa, H. J., Cotton, A. M., et al. Translating dosage compensation to trisomy 21. Nature. 2013 Aug 15;500(7462):296-300. Jänne, P. A., Yang, J. C., Kim, D. W., Planchard, D., Ohe, Y., Ramalingam, S. S., et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J Med. 2015 Apr 30;372(18):1689-1699. Kapranov, P., Cheng, J., Dike, S., Nix, D. A., Duttagupta, R., Willingham, A. T., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007 Jun 8;316(5830):1484-1488. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007 Aug;7(8):573-584. Kenfield, S. A., Wei, E. K., Stampfer, M. J., Rosner, B. A., and Colditz, G. A. Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control. 2008 Jun;17(3):198-204. Kim, J. T., Weiss, H. L., and Evers, B. M. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells. Int J Oncol. 2017 Jun;50(6):2200-2206. Kohno, T., Nakaoku, T., Tsuta, K., Tsuchihara, K., Matsumoto, S., Yoh, K., and Goto, K. Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. Transl Lung Cancer Res. 2015 Apr;4(2):156-164. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., and Xiong, Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011 Apr 21;30(16):1956-1962. Kretz, M., Siprashvili, Z., Chu, C., Webster, D. E., Zehnder, A., Qu, K., et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2013 Jan 10;493(7431):231-235. Kung, J. T., Colognori, D., and Lee, J. T. Long noncoding RNAs: past, present, and future. Genetics. 2013 Mar;193(3):651-669. Kuol, N., Stojanovska, L., Apostolopoulos, V., and Nurgali, K. Role of the nervous system in cancer metastasis. J Exp Clin Cancer Res. 2018 Jan 15;37(1):5. Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018 Aug;24(8):1277-1289. Landsverk, H. B., Sandquist, L. E., Bay, L. T. E., Steurer, B., Campsteijn, C., Landsverk, O. J. B., et al. WDR82/PNUTS-PP1 Prevents Transcription-Replication Conflicts by Promoting RNA Polymerase II Degradation on Chromatin. Cell Rep. 2020 Dec 1;33(9):108469. Lee, H. J., Zhuang, G., Cao, Y., Du, P., Kim, H. J., and Settleman, J. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. Cancer Cell. 2014 Aug 11;26(2):207-221. Lee, J. H., You, J., Dobrota, E., and Skalnik, D. G. Identification and characterization of a novel human PP1 phosphatase complex. J Biol Chem. 2010 Aug 6;285(32):24466-24476. Lee, S. J., Lee, J. K., Maeng, Y. S., Kim, Y. M., and Kwon, Y. G. Langerhans cell protein 1 (LCP1) binds to PNUTS in the nucleus: implications for this complex in transcriptional regulation. Exp Mol Med. 2009 Mar 31;41(3):189-200. Lefrancois, S., Zeng, J., Hassan, A. J., Canuel, M., and Morales, C. R. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. Embo j. 2003 Dec 15;22(24):6430-6437. Li, J., Li, W. X., Bai, C., and Song, Y. Particulate matter-induced epigenetic changes and lung cancer. Clin Respir J. 2017 Sep;11(5):539-546. Li, M. Y., Liu, L. Z., Li, W., Ng, C. S. H., Liu, Y., Kong, A. W. Y., et al. Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis. J Exp Clin Cancer Res. 2019 Aug 16;38(1):359. Li, Q., Jiang, B., Qi, Y., Zhang, H., and Ma, H. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling. Cancer Biol Ther. 2020 Sep 1;21(9):806-814. Li, Q., Zhang, D., Wang, H., Xie, J., Peng, L., Peng, Y., et al. SLCO4A1-AS1 Facilitates the Malignant Phenotype via miR-149-5p/STAT3 Axis in Gastric Cancer Cells. J Oncol. 2021 2021:1698771. Li, W., Sun, M., Zang, C., Ma, P., He, J., Zhang, M., et al. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis. 2016 May 19;7(5):e2225. Li, X., Wan, L., Geng, J., Wu, C. L., and Bai, X. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome. J Thorac Oncol. 2012 Aug;7(8):1235-1245. Li, Y., Li, C., Li, D., Yang, L., Jin, J., and Zhang, B. lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway. Onco Targets Ther. 2019 12:2649-2660. Li, Y., Wang, Z., Shi, H., Li, H., Li, L., Fang, R., et al. HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc. Cancer Res. 2016 Jan 15;76(2):293-304. Liebig, C., Ayala, G., Wilks, J. A., Berger, D. H., and Albo, D. Perineural invasion in cancer: a review of the literature. Cancer. 2009 Aug 1;115(15):3379-3391. Lim, S. M., Hong, M. H., and Kim, H. R. Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives. Immune Netw. 2020 Feb;20(1):e10. Lin, P. C., Huang, H. D., Chang, C. C., Chang, Y. S., Yen, J. C., Lee, C. C., et al. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. BMC Cancer. 2016 Aug 2;16:583. Liu, F., Somarowthu, S., and Pyle, A. M. Visualizing the secondary and tertiary architectural domains of lncRNA RepA. Nat Chem Biol. 2017 Mar;13(3):282-289. Liu, Z., Wu, A., Wu, Z., Wang, T., Pan, Y., Li, B., et al. TOX4 facilitates promoter-proximal pausing and C-terminal domain dephosphorylation of RNA polymerase II in human cells. Commun Biol. 2022 Apr 1;5(1):300. Lobbardi, R., Pinder, J., Martinez-Pastor, B., Theodorou, M., Blackburn, J. S., Abraham, B. J., et al. TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia. Cancer Discov. 2017 Nov;7(11):1336-1353. Lopez-Ayllon, B. D., Moncho-Amor, V., Abarrategi, A., Ibañez de Cáceres, I., Castro-Carpeño, J., Belda-Iniesta, C., et al. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations. Cancer Med. 2014 Oct;3(5):1099-1111. Lopez, D., and Martinez-Luis, S. Marine natural products with P-glycoprotein inhibitor properties. Mar Drugs. 2014 Jan 22;12(1):525-546. Ludovini, V., Bianconi, F., Pistola, L., Chiari, R., Minotti, V., Colella, R., et al. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2011 Apr;6(4):707-715. Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004 May 20;350(21):2129-2139. Ma, X., Zhang, W., Zhang, R., Li, J., Li, S., Ma, Y., et al. Overexpressed long noncoding RNA CRNDE with distinct alternatively spliced isoforms in multiple cancers. Front Med. 2019 Jun;13(3):330-343. Martin, S., Navarro, V., Vincent, J. P., and Mazella, J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology. 2002 Oct;123(4):1135-1143. Martin, S., Vincent, J. P., and Mazella, J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci. 2003 Feb 15;23(4):1198-1205. Matakidou, A., Eisen, T., and Houlston, R. S. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005 Oct 3;93(7):825-833. Matsushita, Y., Yanamoto, S., Takahashi, H., Yamada, S., Naruse, T., Sakamoto, Y., et al. A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma. Int J Oral Maxillofac Surg. 2015 May;44(5):543-548. Mattick, J. S., Amaral, P. P., Carninci, P., Carpenter, S., Chang, H. Y., Chen, L. L., et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023 Jun;24(6):430-447. Maulitz, R. C. Rudolf Virchow, Julius Cohnheim and the program of pathology. Bull Hist Med. 1978 Summer;52(2):162-182. McHugh, C. A., Chen, C. K., Chow, A., Surka, C. F., Tran, C., McDonel, P., et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015 May 14;521(7551):232-236. McLean, G. W., Carragher, N. O., Avizienyte, E., Evans, J., Brunton, V. G., and Frame, M. C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer. 2005 Jul;5(7):505-515. Meador, C. B., and Hata, A. N. Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights. Pharmacol Ther. 2020 Jun;210:107522. Mendelsohn, J., and Baselga, J. The EGF receptor family as targets for cancer therapy. Oncogene. 2000 Dec 27;19(56):6550-6565. Mercer, T. R., Dinger, M. E., and Mattick, J. S. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009 Mar;10(3):155-159. Mercer, T. R., and Mattick, J. S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013 Mar;20(3):300-307. Moody, T. W., Chan, D. C., Mantey, S. A., Moreno, P., and Jensen, R. T. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner. Life Sci. 2014 Mar 28;100(1):25-34. Morchikh, M., Naughtin, M., Di Nunzio, F., Xavier, J., Charneau, P., Jacob, Y., and Lavigne, M. TOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replication. PLoS One. 2013 8(11):e81217. Moreb, J. S., Gabr, A., Vartikar, G. R., Gowda, S., Zucali, J. R., and Mohuczy, D. Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde. J Pharmacol Exp Ther. 2005 Jan;312(1):339-345. Moreb, J. S., Mohuczy, D., Ostmark, B., and Zucali, J. R. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. Cancer Chemother Pharmacol. 2007 Jan;59(1):127-136. Murota, Y., Tabu, K., and Taga, T. Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes. BMC Cancer. 2016 Nov 4;16(1):847. Muscat, J. E., Stellman, S. D., Zhang, Z. F., Neugut, A. I., and Wynder, E. L. Cigarette smoking and large cell carcinoma of the lung. Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):477-480. Mustain, W. C., Rychahou, P. G., and Evers, B. M. The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):75-82. Nielsen, M. S., Jacobsen, C., Olivecrona, G., Gliemann, J., and Petersen, C. M. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999 Mar 26;274(13):8832-8836. Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., et al. The complete sequence of a human genome. Science. 2022 Apr;376(6588):44-53. Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M. C., and Li, G. C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 1996 Aug 8;382(6591):551-555. O'Connor, T. M., O'Connell, J., O'Brien, D. I., Goode, T., Bredin, C. P., and Shanahan, F. The role of substance P in inflammatory disease. J Cell Physiol. 2004 Nov;201(2):167-180. O'Flaherty, E., and Kaye, J. TOX defines a conserved subfamily of HMG-box proteins. BMC Genomics. 2003 Apr 2;4(1):13. Ocejo-Garcia, M., Ahmed, S. I., Coulson, J. M., and Woll, P. J. Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer. Lung Cancer. 2001 Jul;33(1):1-9. Ohashi, K., Maruvka, Y. E., Michor, F., and Pao, W. Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease. J Clin Oncol. 2013 Mar 10;31(8):1070-1080. Olivero, C. E., Martínez-Terroba, E., Zimmer, J., Liao, C., Tesfaye, E., Hooshdaran, N., et al. p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis. Mol Cell. 2020 Feb 20;77(4):761-774.e768. Ortiz-Cuaran, S., Scheffler, M., Plenker, D., Dahmen, L., Scheel, A. H., Fernandez-Cuesta, L., et al. Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors. Clin Cancer Res. 2016 Oct 1;22(19):4837-4847. Ouyang, Q., Zhou, J., Yang, W., Cui, H., Xu, M., and Yi, L. Oncogenic role of neurotensin and neurotensin receptors in various cancers. Clin Exp Pharmacol Physiol. 2017 Aug;44(8):841-846. Ouyang, S., Zhou, X., Chen, Z., Wang, M., Zheng, X., and Xie, M. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 2019 19:72. Pa, M., Naizaer, G., Seyiti, A., and Kuerbang, G. Long Noncoding RNA MALAT1 Functions as a Sponge of MiR-200c in Ovarian Cancer. Oncol Res. 2017 Sep 11. Page, N., Klimek, B., De Roo, M., Steinbach, K., Soldati, H., Lemeille, S., et al. Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8(+) T Cells. Immunity. 2018 May 15;48(5):937-950.e938. Pan, Z., Zhu, Q., You, W., Shen, C., Hu, W., and Chen, X. Silencing of Mig-7 expression inhibits in-vitro invasiveness and vasculogenic mimicry of human glioma U87 Cells. Neuroreport. 2019 Dec 10;30(17):1135-1142. Parsons, J. T. Focal adhesion kinase: the first ten years. J Cell Sci. 2003 Apr 15;116(Pt 8):1409-1416. Petermann, E., Lan, L., and Zou, L. Sources, resolution and physiological relevance of R-loops and RNA-DNA hybrids. Nat Rev Mol Cell Biol. 2022 Aug;23(8):521-540. Pirker, R. Conquering lung cancer: current status and prospects for the future. Pulmonology. 2020 Sep-Oct;26(5):283-290. Pope, C. A., 3rd, Burnett, R. T., Thun, M. J., Calle, E. E., Krewski, D., Ito, K., and Thurston, G. D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. Jama. 2002 Mar 6;287(9):1132-1141. Pozojevic, J., Algodon, S. M., Cruz, J. N., Trinh, J., Brüggemann, N., Laß, J., et al. Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon. Int J Mol Sci. 2022 Feb 17;23(4). Prensner, J. R., and Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011 Oct;1(5):391-407. Raaschou-Nielsen, O., Pedersen, M., Stafoggia, M., Weinmayr, G., Andersen, Z. J., Galassi, C., et al. Outdoor air pollution and risk for kidney parenchyma cancer in 14 European cohorts. Int J Cancer. 2017 Apr 1;140(7):1528-1537. Reeves, R. Nuclear functions of the HMG proteins. Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):3-14. Rinn, J. L., and Chang, H. Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012 81:145-166. Rittmeyer, A., Barlesi, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017 Jan 21;389(10066):255-265. Rosa, R., Villegas-Ruíz, V., Caballero-Palacios, M. C., Pérez-López, E. I., Murata, C., Zapata-Tarres, M., et al. Expression of ZNF695 Transcript Variants in Childhood B-Cell Acute Lymphoblastic Leukemia. Genes (Basel). 2019 Sep 16;10(9). Rotow, J., and Bivona, T. G. Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer. 2017 Oct 25;17(11):637-658. Saada, S., Marget, P., Fauchais, A. L., Lise, M. C., Chemin, G., Sindou, P., et al. Differential expression of neurotensin and specific receptors, NTSR1 and NTSR2, in normal and malignant human B lymphocytes. J Immunol. 2012 Dec 1;189(11):5293-5303. Saleh, R., Taha, R. Z., Toor, S. M., Sasidharan Nair, V., Murshed, K., Khawar, M., et al. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer. Cancer Immunol Immunother. 2020 Oct;69(10):1989-1999. Schlaepfer, D. D., and Mitra, S. K. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev. 2004 Feb;14(1):92-101. Seehus, C. R., Aliahmad, P., de la Torre, B., Iliev, I. D., Spurka, L., Funari, V. A., and Kaye, J. The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor. Nat Immunol. 2015 Jun;16(6):599-608. Seo, H., Chen, J., González-Avalos, E., Samaniego-Castruita, D., Das, A., Wang, Y. H., et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion. Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12410-12415. Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011 Mar 23;3(75):75ra26. Shackelford, R. E., Vora, M., Mayhall, K., and Cotelingam, J. ALK-rearrangements and testing methods in non-small cell lung cancer: a review. Genes Cancer. 2014 Apr;5(1-2):1-14. Shao, C., Sullivan, J. P., Girard, L., Augustyn, A., Yenerall, P., Rodriguez-Canales, J., et al. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Clin Cancer Res. 2014 Aug 1;20(15):4154-4166. Sharma, S., Findlay, G. M., Bandukwala, H. S., Oberdoerffer, S., Baust, B., Li, Z., et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11381-11386. Shi, L., Magee, P., Fassan, M., Sahoo, S., Leong, H. S., Lee, D., et al. A KRAS-responsive long non-coding RNA controls microRNA processing. Nat Commun. 2021 Apr 1;12(1):2038. Shi, T., Gao, G., and Cao, Y. Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics. Dis Markers. 2016 2016:9085195. Shi, Y. Serine/threonine phosphatases: mechanism through structure. Cell. 2009 Oct 30;139(3):468-484. Siegel, R. L., Miller, K. D., Fuchs, H. E., and Jemal, A. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7-33. Siegelin, M. D., and Borczuk, A. C. Epidermal growth factor receptor mutations in lung adenocarcinoma. Lab Invest. 2014 Feb;94(2):129-137. Slack, F. J., and Chinnaiyan, A. M. The Role of Non-coding RNAs in Oncology. Cell. 2019 Nov 14;179(5):1033-1055. Socinski, M. A., Villaruz, L. C., and Ross, J. Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression. Oncologist. 2017 Jan;22(1):3-11. Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007 Aug 2;448(7153):561-566. Statello, L., Guo, C. J., Chen, L. L., and Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118. Sullivan, J. P., Spinola, M., Dodge, M., Raso, M. G., Behrens, C., Gao, B., et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010 Dec 1;70(23):9937-9948. Sun, M., Liu, X. H., Wang, K. M., Nie, F. Q., Kong, R., Yang, J. S., et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014 Mar 21;13:68. Sun, Y., Zhou, Y., Bai, Y., Wang, Q., Bao, J., Luo, Y., et al. A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol Cancer. 2017 Oct 17;16(1):162. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. Takahashi, K., Ehata, S., Miyauchi, K., Morishita, Y., Miyazawa, K., and Miyazono, K. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Mol Oncol. 2021 Jan;15(1):151-166. Tan, D. S. W., Chong, F. T., Leong, H. S., Toh, S. Y., Lau, D. P., Kwang, X. L., et al. Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma. Nat Med. 2017 Oct;23(10):1167-1175. Tan, J. Y., and Marques, A. C. The activity of human enhancers is modulated by the splicing of their associated lncRNAs. PLoS Comput Biol. 2022 Jan;18(1):e1009722. Tang, R., Chen, J., Tang, M., Liao, Z., Zhou, L., Jiang, J., et al. LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer. Int J Biol Sci. 2019 15(13):2885-2896. Tang, Z., Li, C., Kang, B., Gao, G., Li, C., and Zhang, Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul 3;45(W1):W98-w102. Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nat Med. 2015 Jun;21(6):560-562. Tian, H., Lian, R., Li, Y., Liu, C., Liang, S., Li, W., et al. AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation. Nat Commun. 2020 Oct 12;11(1):5127. Tiemann, U., Sgodda, M., Warlich, E., Ballmaier, M., Schöler, H. R., Schambach, A., and Cantz, T. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Cytometry A. 2011 Jun;79(6):426-435. Tsai, M. C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010 Aug 6;329(5992):689-693. Turner, M. C., Chen, Y., Krewski, D., Calle, E. E., and Thun, M. J. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007 Aug 1;176(3):285-290. Vanheer, L., Song, J., De Geest, N., Janiszewski, A., Talon, I., Provenzano, C., et al. Tox4 modulates cell fate reprogramming. J Cell Sci. 2019 Oct 22;132(20). Vincent, J. P., Mazella, J., and Kitabgi, P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci. 1999 Jul;20(7):302-309. Vokes, E. E., Ready, N., Felip, E., Horn, L., Burgio, M. A., Antonia, S. J., et al. Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases. Ann Oncol. 2018 Apr 1;29(4):959-965. Volders, P. J., Helsens, K., Wang, X., Menten, B., Martens, L., Gevaert, K., et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 2013 Jan;41(Database issue):D246-251. Vong, Q. P., Leung, W. H., Houston, J., Li, Y., Rooney, B., Holladay, M., et al. TOX2 regulates human natural killer cell development by controlling T-BET expression. Blood. 2014 Dec 18;124(26):3905-3913. Voronkova, M. A., Rojanasakul, L. W., Kiratipaiboon, C., and Rojanasakul, Y. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer. Mol Cell Biol. 2020 Jan 3;40(2). Wang, D., and Lippard, S. J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005 Apr;4(4):307-320. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008 Nov 27;456(7221):470-476. Wang, K., Li, M., Duan, H., Fan, M., Xu, C., and Yu, F. SLCO4A1-AS1 triggers the malignant behaviours of melanoma cells via sponging miR-1306-5p to enhance PCGF2. Exp Dermatol. 2022 Aug;31(8):1220-1233. Wang, X., and Adjei, A. A. Lung cancer and metastasis: new opportunities and challenges. Cancer Metastasis Rev. 2015 Jun;34(2):169-171. Wang, Y., McKay, J. D., Rafnar, T., Wang, Z., Timofeeva, M. N., Broderick, P., et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul;46(7):736-741. Wang, Z., and Jin, J. LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis. Aging (Albany NY). 2019 Jul 16;11(14):4876-4889. Wei, Y., Wei, L., Li, J., Ma, Z., Zhang, Q., Han, Z., and Li, S. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway. Cancer Med. 2020 Oct;9(19):7205-7217. Welch, D. R., and Hurst, D. R. Defining the Hallmarks of Metastasis. Cancer Res. 2019 Jun 15;79(12):3011-3027. Winkler, L., Jimenez, M., Zimmer, J. T., Williams, A., Simon, M. D., and Dimitrova, N. Functional elements of the cis-regulatory lincRNA-p21. Cell Rep. 2022 Apr 19;39(3):110687. Wu, C. H., Hsu, C. L., Lu, P. C., Lin, W. C., Juan, H. F., and Huang, H. C. Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules. Sci Rep. 2016 Oct 27;6:35939. Wu, C. J., Cho, S., Huang, H. Y., Lu, C. H., Russ, J., Cruz, L. O., et al. MiR-23~27~24-mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation. Sci Adv. 2019 Dec;5(12):eaaw1715. Wu, D. C., Wang, S. S. W., Liu, C. J., Wuputra, K., Kato, K., Lee, Y. L., et al. Reprogramming Antagonizes the Oncogenicity of HOXA13-Long Noncoding RNA HOTTIP Axis in Gastric Cancer Cells. Stem Cells. 2017 Oct;35(10):2115-2128. Wu, W., Wagner, E. K., Hao, Y., Rao, X., Dai, H., Han, J., et al. Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer. Sci Rep. 2016 Sep 6;6:32731. Wu, Z., Fournel, L., Stadler, N., Liu, J., Boullier, A., Hoyeau, N., et al. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody. Cancer Lett. 2019 Mar 1;444:147-161. Xhemalce, B. From histones to RNA: role of methylation in cancer. Brief Funct Genomics. 2013 May;12(3):244-253. Xia, W., Zhuang, L., Deng, X., and Hou, M. Long noncoding RNA‑p21 modulates cellular senescence via the Wnt/β‑catenin signaling pathway in mesenchymal stem cells. Mol Med Rep. 2017 Nov;16(5):7039-7047. Xiao, Z. J., Liu, J., Wang, S. Q., Zhu, Y., Gao, X. Y., Tin, V. P., et al. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma. Elife. 2017 Jul 24;6. Xin Yu, J., Hubbard-Lucey, V. M., and Tang, J. Immuno-oncology drug development goes global. Nat Rev Drug Discov. 2019 Nov;18(12):899-900. Xu, W., Zhao, X., Wang, X., Feng, H., Gou, M., Jin, W., et al. The Transcription Factor Tox2 Drives T Follicular Helper Cell Development via Regulating Chromatin Accessibility. Immunity. 2019 Nov 19;51(5):826-839.e825. Yamanaka, A., Hirai, T., Ohtake, Y., and Kitagawa, M. Lung cancer associated with Werner's syndrome: a case report and review of the literature. Jpn J Clin Oncol. 1997 Dec;27(6):415-418. Yang, C. Y., Yang, J. C., and Yang, P. C. Precision Management of Advanced Non-Small Cell Lung Cancer. Annu Rev Med. 2020 Jan 27;71:117-136. Yang, F., Zhang, L., Huo, X. S., Yuan, J. H., Xu, D., Yuan, S. X., et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011 Nov;54(5):1679-1689. Yang, L., Xue, Y., Liu, J., Zhuang, J., Shen, L., Shen, B., et al. Long noncoding RNA ASAP1-IT1 promotes cancer stemness and predicts a poor prognosis in patients with bladder cancer. Neoplasma. 2017 64(6):847-855. Yang, P. Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol. 2009 471:469-486. Yang, P., Sun, Z., Krowka, M. J., Aubry, M. C., Bamlet, W. R., Wampfler, J. A., et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008 May 26;168(10):1097-1103. Yang, X., Yang, J., Lei, P., and Wen, T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging (Albany NY). 2019 Oct 26;11(20):8777-8791. Yang, Y., Wang, F., Huang, H., Zhang, Y., Xie, H., and Men, T. lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4. Onco Targets Ther. 2019 12:1351-1358. Ye, Y., Long, X., Zhang, L., Chen, J., Liu, P., Li, H., et al. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma. Oncotarget. 2016 Oct 25;7(43):70303-70322. Yin, D., Lu, X., Su, J., He, X., De, W., Yang, J., et al. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018 May 24;17(1):92. Ying, L., Chen, Q., Wang, Y., Zhou, Z., Huang, Y., and Qiu, F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst. 2012 Sep;8(9):2289-2294. Younes, M., Wu, Z., Dupouy, S., Lupo, A. M., Mourra, N., Takahashi, T., et al. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib. Oncotarget. 2014 Sep 30;5(18):8252-8269. Yu, J., Han, Z., Sun, Z., Wang, Y., Zheng, M., and Song, C. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. J Exp Clin Cancer Res. 2018 Sep 10;37(1):222. Yuan, S. H., Qiu, Z., and Ghosh, A. TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2909-2914. Yun, C. H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K. K., et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2070-2075. Zappa, C., and Mousa, S. A. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016 Jun;5(3):288-300. Zeng, D., Lin, H., Cui, J., and Liang, W. TOX3 is a favorable prognostic indicator and potential immunomodulatory factor in lung adenocarcinoma. Oncol Lett. 2019 Oct;18(4):4144-4152. Zhang, H. Osimertinib making a breakthrough in lung cancer targeted therapy. Onco Targets Ther. 2016 9:5489-5493. Zhang, J., Cui, K., Huang, L., Yang, F., Sun, S., Bian, Z., et al. SLCO4A1-AS1 promotes colorectal tumourigenesis by regulating Cdk2/c-Myc signalling. J Biomed Sci. 2022 Jan 17;29(1):4. Zhang, J., Shen, Y., Ma, D., Li, Z., Zhang, Z., and Jin, W. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis. Open Med (Wars). 2022 17(1):253-265. Zhang, K., Yang, L., Wang, J., Sun, T., Guo, Y., Nelson, R., et al. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer. Cell Commun Signal. 2019 Dec 16;17(1):167. Zhang, Y., Li, Z., Zhang, Y., Zhong, Q., Chen, Q., and Zhang, L. Molecular mechanism of HEIH and HULC in the proliferation and invasion of hepatoma cells. Int J Clin Exp Med. 2015 8(8):12956-12962. Zhao, D., and Pothoulakis, C. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides. 2006 Oct;27(10):2434-2444. Zhou, Y., Wang, H., Gong, H., Cao, M., Zhang, G., and Wang, Y. Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pract. 2015 Nov;211(11):839-844. Zhu, L., Wei, Q., Qi, Y., Ruan, X., Wu, F., Li, L., et al. PTB-AS, a Novel Natural Antisense Transcript, Promotes Glioma Progression by Improving PTBP1 mRNA Stability with SND1. Mol Ther. 2019 Sep 4;27(9):1621-1637. Zhu, S., Tian, H., Niu, X., Wang, J., Li, X., Jiang, N., et al. Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer. Oncogene. 2019 Jun;38(24):4875-4884. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/94834 | - |
| dc.description.abstract | 轉移過程涉及癌細胞遷移和侵襲的多種步驟過程，是癌症惡性腫瘤的重要特徵。在細胞內，無法轉譯成蛋白質且長度大於兩百鹼基的長鏈非編碼RNA (Long non-coding RNAs; lncRNA) 已經被證實在癌細胞轉移調節中發揮著關鍵作用。本研究發現lncRNA Solute carrier organic anion transporter family member 4A1- antisense 1 (SLCO4A1-AS1) 具有腫瘤抑制因子的功能，在肺癌細胞中表現出抗轉移性與抑制癌幹細胞族群的擴增。此外SLCO4A1-AS1也能夠抑制磷酸化FAK與paxillin的表現量以及細胞骨架 (cytoskeleton filaments)，進而減少癌細胞遷移和侵襲，並與肺腺癌患者更長的總生存期相關。經次世代定序及功能分析發現SLCO4A1-AS1會影響與細胞運動能力相關的基因。並且透過RNA pull-down、蛋白質質譜分析以及RNA immunoprecipitation發現SLCO4A1-AS1直接與DNA結合蛋白 TOX High Mobility Group Box Family Member 4 (TOX4) 相互作用，並且限制由TOX4誘導的遷移和侵襲能力。另外建立SLCO4A1-AS1 與TOX4過表達的細胞株並且執行次世代定序分析發現，neurotensin receptor 1 (NTSR1) 為SLCO4A1-AS1 和 TOX4 的一個新的重要下游標的。從機制上來看，SLCO4A1-AS1作為TOX4的誘餌 (decoy) 並且通過阻斷TOX4與NTSR1啟動子的相互作用進而阻止NTSR1轉錄。從功能上來說，NTSR1通過細胞骨架重塑促進癌細胞遷移和侵襲，NTSR1的沉默顯著的抑制由TOX4誘導的遷移和侵襲能力。綜上所述，這證據顯示了SLCO4A1-AS1拮抗TOX4/NTSR1信號傳導，並在抑制肺癌細胞遷移和侵襲中發揮關鍵作用。
本研究的目標在於肺腺癌中開發未知的lncRNA並探討其在腫瘤調控中的生理功能。同時，我們還希望釐清癌症、基因及生物訊息之間複雜的關係，並且期望研究成果除了能成為癌症早期診斷的生物標誌，並對癌症治療提供分子標的。希望最終能應用於臨床上抗癌藥物的開發及拓展新的治療策略。 | zh_TW |
| dc.description.abstract | Metastasis is a multistep process involving the migration and invasion of cancer cells, which is a hallmark of cancer malignancy. Recently, it has been discovered that long non-coding RNAs (lncRNAs), which are RNA molecules longer than two hundred base pairs and cannot be translated into proteins, play crucial roles in regulating the metastasis of cancer cells. This study discovered that the lncRNA solute carrier organic anion transporter family member 4A1-antisense 1 (SLCO4A1-AS1) acts as a tumor suppressor. It exhibits anti-metastatic properties and inhibits the expansion of cancer stem cell population in lung cancer cells. Additionally, SLCO4A1-AS1 has the ability to reduce cancer cell migration and invasion by inhibiting the phospho-FAK and phosphor-paxillin, as well as disrupting cytoskeleton filaments. This lncRNA is also associated with longer overall survival in lung adenocarcinoma patients. Through next-generation sequencing and functional analysis, it was found that SLCO4A1-AS1 affects genes related to cell movement. Furthermore, using techniques such as RNA pull-down, protein mass spectrometry analysis, and RNA immunoprecipitation, it was discovered that SLCO4A1-AS1 directly interacts with the DNA-binding protein TOX High Mobility Group Box Family Member 4 (TOX4) thereby restricting TOX4-induced migration and invasion. Furthermore, the establishment of cell lines overexpressing SLCO4A1-AS1 and TOX4, followed by next-generation sequencing analysis, revealed that neurotensin receptor 1 (NTSR1) is a novel and convergent downstream target of SLCO4A1-AS1 and TOX4. Mechanistically, SLCO4A1-AS1 acts as a decoy for TOX4 and blocks the interaction between TOX4 and the NTSR1 promoter, thereby inhibiting NTSR1 transcription. Functionally, NTSR1 promotes cancer cell migration and invasion by remodeling the cytoskeleton, and silencing NTSR1 significantly inhibits the migration and invasion induced by TOX4. In summary, this evidence shows that SLCO4A1-AS1 antagonizes the TOX4/NTSR1 signaling pathway and plays a key role in inhibiting lung cancer cell migration and invasion.
The purpose of this study is to develop unknown lncRNAs in lung adenocarcinoma and explore their physiological functions in tumor regulation. Additionally, we aim to understand the intricate connections between cancer, genes, and biological information, with the goal of identifying potential biomarkers for early cancer detection and molecular targets for cancer therapy. Ultimately, these findings could contribute to the development of anticancer drugs and the exploration of novel treatment approaches in clinical settings. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-19T17:17:56Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2024-08-19T17:17:56Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 目次
口試委員審定書 i 誌謝 ii 中文摘要及關鍵詞 iii 英文摘要及關鍵詞 v 目次 vii 表次 x 圖次 xi 附錄 xiii 第一章 緒論 (Introduction) 1 第一節 肺癌 (lung cancer) 1 第二節 長鏈非編碼RNA (Long non-coding RNA; LncRNA) 6 第三節 LncRNAs的功能與機制 7 第四節 LncRNAs在癌症中的角色 9 第五節 LncRNA SLCO4A1-AS1調控癌症生物功能之相關研究 14 第六節 TOX4 (TOX High Mobility Group Box Family Member 4) 的研究背景 15 第七節 NTSR1 (Neurotensin receptor 1) 的研究背景 18 第八節 研究的假說及特定目的 20 第二章 研究方法與材料 22 第三章 結果 29 第一節 在高度轉移性肺癌細胞與非小細胞肺癌患者中的SLCO4A1-AS1表達量減少 29 第二節 SLCO4A1-AS1的生物功能富集分析 (functional enrichment analysis) 30 第三節 SLCO4A1-AS1在肺癌細胞中扮演腫瘤抑制的角色 31 第四節 SLCO4A1-AS1與TOX4交互作用 (interaction) 34 第五節 SLCO4A1-AS1過度表達逆轉TOX4所誘導的癌細胞遷移和侵襲能力 35 第六節 SLCO4A-AS1阻斷TOX4與NTSR1啟動子結合並抑制NTSR1的表達 36 第七節 NTSR1在SLCO4A1-AS1/TOX4調控遷移和侵襲功能中的重要性 38 第八節 結論 39 第四章 討論 40 第一節 SLCO4A1-AS1扮演肺腫瘤抑制的角色 40 第二節 不同的SLCO4A1-AS1 transcripts對於TOX4/NTSR1生物功能的調控 43 第三節 TOX4 在肺癌細胞中調控細胞遷移和侵襲 45 第四節 SLCO4A1-AS1 抑制癌症幹細胞族群 48 第五節 SLCO4A1-AS1抑制小鼠肺癌細胞的轉移 52 第六節 SLCO4A-AS1干擾TOX4與NTSR1啟動子結合並抑制NTSR1的表達 54 第七節 NTSR1在SLCO4A1-AS1/TOX4調控遷移和侵襲功能中的重要性 57 第八節 結論與需要釐清的問題 60 第五章 展望 64 第一節 非小細胞肺癌目前治療的困境 64 第二節 本研究對於非小細胞肺癌的臨床診斷及治療的影響 67 第三節 本研究對之後lncRNAs調控非小細胞肺癌進展基礎研究的影響 70 第四節 未來的研究規劃 72 第六章 論文英文簡述 74 第七章 參考文獻 91 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | SLCO4A1-AS1 | zh_TW |
| dc.subject | 肺癌 | zh_TW |
| dc.subject | 細胞骨架 | zh_TW |
| dc.subject | 長鏈非編碼核醣核酸 | zh_TW |
| dc.subject | 轉移 | zh_TW |
| dc.subject | SLCO4A1-AS1 | en |
| dc.subject | Metastasis | en |
| dc.subject | Cytoskeleton | en |
| dc.subject | Lung cancer | en |
| dc.subject | Long non-coding RNA | en |
| dc.title | 長鏈非編碼核醣核酸-SLCO4A1-AS1在肺癌進展的角色 | zh_TW |
| dc.title | The function of long non-coding RNA-SLCO4A1-AS1 in the progression of lung cancer | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 112-2 | - |
| dc.description.degree | 博士 | - |
| dc.contributor.coadvisor | 廖唯昱 | zh_TW |
| dc.contributor.coadvisor | Wei-Yu Liao | en |
| dc.contributor.oralexamcommittee | 周祖述;林家齊;蔡孟峯;許晉銓 | zh_TW |
| dc.contributor.oralexamcommittee | Tzuu-Shuh Jou;Chia-Chi Lin;Meng-Feng Tsai;Jinn-Chyuan Sheu | en |
| dc.subject.keyword | SLCO4A1-AS1,長鏈非編碼核醣核酸,細胞骨架,轉移,肺癌, | zh_TW |
| dc.subject.keyword | SLCO4A1-AS1,Long non-coding RNA,Cytoskeleton,Metastasis,Lung cancer, | en |
| dc.relation.page | 162 | - |
| dc.identifier.doi | 10.6342/NTU202400892 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2024-04-26 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 臨床醫學研究所 | - |
| dc.date.embargo-lift | 2027-04-30 | - |
| 顯示於系所單位： | 臨床醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-112-2.pdf 未授權公開取用 | 6.65 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。